E-Book, Englisch, 560 Seiten
Bellinger Human Developmental Neurotoxicology
Erscheinungsjahr 2006
ISBN: 978-1-4200-1852-3
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
E-Book, Englisch, 560 Seiten
ISBN: 978-1-4200-1852-3
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
This reference describes the most recent developments in the design, execution, and interpretation of human developmental neurotoxicology studies. Assessing critical issues and controversies in the field, this guide focuses on dose-response/effect relationships and explores challenges in the measurement of exposure to different types of chemicals, including selected metals, organic pollutants, pesticides, and recreational and therapeutic drugs.
Zielgruppe
Epidemiologists, toxicologists, biostatisticians, specialists in risk assessment, and researchers in the field.
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Naturwissenschaften Biowissenschaften Entwicklungsbiologie
Weitere Infos & Material
Introduction. Lead. Alcohol. EMERGING STORIES: OUTSTANDING ISSUES AND DATA NEEDS. PART A: ENVIRONMENTAL CHEMICALS. Methylmercury. Polychlorinated Biphenyls. Solvents. Pesticides. PART B: MEDICINALS. Retinoids. Chemotherapeutic Drugs. PART C: RECREATIONAL SUBSTANCE USE. Maternal Smoking During Pregnancy and ETS. Cocaine. IMPROVING THE ASSESSMENT OF THE RELATIONSHIPS BETWEEN EXPOSURE AND CLINICAL DISEASE: DATA AND METHODS NEEDS. PART 1: EXPOSURE ASSESSMENT AND PHARMACOKINETIC MODELS. Metals. Pesticides. Drugs of Abuse. PART 2: ENDPOINT ASSESSMENT. Parallels Between Animal and Human Models of Nerobehavioral Disorders: General Considerations. Neuropsycchological Assessment Issues and Strategies. Role of Neuroimaging. Childhood Exposures and Adult Disease. PART 3: DATA ANALYSIS AND DEFINING BASES OF INDIVIDUAL SUSEPTIBILITY. The Experimentalist Perspective. Applications of Structural Equation Modeling. The Social-Ecological Perspective. Molecular Mechanisms. PART 4: INCREASING THE RELEVANCE AND UTILITY OF DATA FROM DEVELOPMENTAL NEUROTOXICITY STUDIES TO CLINICAL PRACTICE AND TO RISK ASSESSMENT. Ethical Considerations. The Political and Economic Contexts. Clinician Perspective. Public Health Perspective.
